NATRELLE TE SMOOTH 133S-MV-13-T
Report
- Report Number
- 9617229-2026-01526
- Event Type
- Injury
- Date Received
- January 23, 2026
- Report Date
- February 24, 2026
- Manufacturer
- ALLERGAN (COSTA RICA)
- Product Code
- LCJ
- UDI-DI
- 10888628043879
- PMA / PMN Number
- K182054
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- OH, US
- Reporter Occupation
- PHYSICIAN
- Health Professional
- Yes
Narratives
A REVIEW OF THE DEVICE HISTORY RECORD HAS BEEN COMPLETED. NO DEVIATIONS OR NON-CONFORMANCES NOTED. DEVICE EVALUATION: THE DEVICE RELATED TO THE REPORTED EVENTS DEFLATION WAS RECEIVED ON FEBRUARY 11, 2026, WITH LOT NUMBER 1241882. PER THE INVESTIGATION PROCEDURE, THE DEVICE IS ANALYZED THROUGH VISUAL INSPECTION MICROSCOPIC INSPECTION IF OPENINGS ARE OBSERVED AND A WEIGHT VERIFICATION (IF APPLICABLE). PER THE ANALYSIS PERFORMED, THE ASSESSMENTS OF THE COMPLAINTS AND ANY POTENTIAL MANUFACTURING ISSUE ARE DISPLAYED ALONG WITH ANY FURTHER ACTIONS REQUIRED: ¿ DEFLATION: OBSERVED AN OPENING THROUGH MICROSCOPIC INSPECTION ASSESSED AS UNIDENTIFIED (TEAR) OPENING. NO FURTHER ACTIONS ARE REQUIRED AS IT IS NOT RELATED TO THE MANUFACTURING PROCESS. NO ADDITIONAL OBSERVATIONS PERFORMED ON THE DEVICE. NO FURTHER ACTIONS ARE REQUIRED.
FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT, PRODUCT, OR PATIENT DETAILS HAS BEEN REQUESTED. NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME. REASON FOR REOPERATION: DEFLATION.
HEALTHCARE PROFESSIONAL REPORTED "TISSUE EXPANDER WAS DEFLATED UPON REMOVAL". THIS RECORD IS FOR AN UNKNOWN SIDE. THE DEVICE WAS EXPLANTED.
HEALTHCARE PROFESSIONAL REPORTED "TISSUE EXPANDER WAS DEFLATED UPON REMOVAL". THIS RECORD IS FOR AN UNKNOWN SIDE. THE DEVICE WAS EXPLANTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 224314 | NATRELLE TE SMOOTH 133S-MV-13-T | EXPANDER, SKIN, INFLATABLE | LCJ | ALLERGAN (COSTA RICA) | 1241882 | 10888628043879 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | NA | Female | Required Intervention |